About ANAB

AnaptysBio is a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation. The companys proprietary anti-inflammatory pipeline includes its anti-IL-33 antibody (ANB020) for the treatment of moderate-to-severe adult atopic dermatitis, severe adult peanut allergy and severe adult eosinophilic asthma; its anti-IL-36R antibody (ANB019) for the treatment of rare inflammatory diseases, including generalized pustular psoriasis and palmo-plantar pustular psoriasis; and a portfolio of checkpoint receptor agonist antibodies for the treatment of certain autoimmune diseases where immune checkpoint receptors are insufficiently activated and have demonstrated efficacy in an animal model of graft-versus-host disease. AnaptysBios antibody pipeline has been developed using its proprietary somatic hypermutation (SHM) platform, which uses in vitro SHM for antibody discovery and is designed to replicate key features of the human immune system to overcome the limitations of competing antibody discovery technologies. AnaptysBio has also developed multiple therapeutic antibodies in an immuno-oncology partnership with TESARO and an inflammation partnership with Celgene, including an anti-PD-1 antagonist antibody (TSR-042) and an anti-TIM-3 antagonist antibody (TSR-022), which are currently under clinical development with TESARO, and an anti-PD-1 checkpoint agonist antibody (CC-90006) currently in the clinic with Celgene.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ANAB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 212.2 M 2.1215E+08 234 234 0.08% 0.000834722 388 K 388418
UBIO Proshares UltraPro Nasdaq Biotechnology 28.4 M 2.839E+07 227 227 0.05% 0.000535626 50 K 49630
URTY ProShares UltraPro Russell2000 90.7 M 9.07335E+07 1,993 1993 0.01% 0.000133971 40 K 39857
UWM ProShares Ultra Russell2000 158.8 M 1.5876E+08 1,992 1992 0.02% 0.000225354 78 K 77848
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.0 B 1.9731E+09 1,475 1475 0.01% 0.00011 227 K 226540
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39704E+09 2,261 2261 0.01% 7.7E-05 105 K 104607
VB Vanguard Small-Cap ETF 23.6 B 2.36E+10 1,376 1376 0.04% 0.00044 10.5 M 1.05151E+07
VBR Vanguard Small-Cap Value ETF 12.6 B 1.26E+10 844 844 0.08% 0.00084 10.6 M 1.0565E+07
VHT Vanguard Health Care ETF 8.7 B 8.7E+09 393 393 0.05% 0.00046 4.0 M 4013120
VTHR Vanguard Russell 3000 ETF 424.7 M 4.247E+08 2,959 2959 0.01% 6E-05 23 K 23418
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.01% 6E-05 6.1 M 6118190
VTWG Vanguard Russell 2000 Growth ETF 282.8 M 2.828E+08 1,257 1257 0.15% 0.00153 432 K 432064
VTWO Vanguard Russell 2000 ETF 1.4 B 1.4E+09 2,010 2010 0.08% 0.00079 1.1 M 1116370
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.04% 0.00036 2.3 M 2346460
LABU Direxion Daily S&P Biotech Bull 3X Shares 568.8 M 5.68759E+08 130 130 0.11% 0.00106935 2.1 M 2137370
IBB iShares Nasdaq Biotechnology Index Fund 7.4 B 7.39335E+09 221 221 0.2% 0.002 14.5 M 1.45379E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.1005E+10 3,548 3548 0.0% 0 900 K 900241
IWM iShares Russell 2000 ETF 41.2 B 4.1238E+10 1,983 1983 0.06% 0.0006 23.7 M 2.36801E+07
IWO iShares Russell 2000 Growth ETF 8.9 B 8.91978E+09 1,229 1229 0.11% 0.0011 9.7 M 9659760
IWV iShares Russell 3000 ETF 9.4 B 9.37678E+09 2,927 2927 0.0% 0 372 K 371773
JKL iShares Morningstar Small-Cap Value ETFnd 400.4 M 4.00397E+08 242 242 0.21% 0.0021 833 K 833248
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.4 B 4.37881E+09 121 121 0.6% 0.00595718 26.1 M 2.614031E+07
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 369 369 0.03% 0.000318607 504 K 503931
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000159633 336 K 335534